Vaxcyte, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vaxcyte, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2025.
  • Vaxcyte, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2025 was $85.6M, a 220% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $85.6M +$58.9M +220% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $87.8M +$58.9M +204% Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $72.1M +$41.1M +133% Dec 31, 2024 10-Q 2025-08-06
Q3 2024 $28.7M +$12.4M +75.7% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $26.8M +$8.77M +48.7% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $28.9M +$9.25M +47% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $31M +$9.71M +45.6% Dec 31, 2023 10-K 2025-02-25
Q3 2023 $16.3M -$6.55M -28.6% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $18M -$6.55M -26.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $19.7M -$6.46M -24.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $21.3M -$6.67M -23.9% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $22.9M +$22.6M +7355% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $24.6M +$23.9M +3655% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $26.1M +$25.1M +2441% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $28M +$27.1M +3006% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $307K Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $654K Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.03M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $900K Jan 1, 2021 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.